Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Chemoendocrine therapies compared for treatment of breast cancer
October 20th, 2005
Chemoendocrine therapies were compared in a study for the treatment of breast cancer. "Chemotherapy, tamoxifen, and ovarian ablation/suppression (OA/OS) are effective adjuvant approaches for premenopausal, steroid hormone receptor-positive breast cancer," report scientists in the United States. "The value of combined therapy has not been clearly established." N. E. Davidson and colleagues assigned "Premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer (1,503 eligible patients) randomly to six cycles of cyclophosphamide, doxorubicin, and fluorouracil (CAF), CAF followed by 5 years of monthly goserelin...
Source: Women's Health Weekly (2005-10-20)
|
